Insights into ASX Stocks

Orthocell (ASX: OCC): Prostate Pilot Could Add US$400 Million to Remplir’s US Market

Oct 14, 2026

Proactive Equities Team

Orthocell (ASX: OCC) reports encouraging early recovery results from a five-patient Remplir prostatectomy pilot, with no Remplir-related complications over about 12 months, and plans a larger trial to support a US push without new regulatory approvals.

Cogstate (ASX: CGS): Mood Disorder Trial Wins Build a US$143.7 Million Revenue Backlog

Oct 13, 2026

Proactive Equities Team

Cogstate (ASX: CGS) opened FY27 with US$25.1 million of new sales contracts, led by five Phase 3 mood disorder trials, lifting contracted revenue to US$143.7 million and giving the company a longer, clearer runway for future earnings.

Alvo Minerals (ASX: ALV): Bluebush Progress Meets Breakout Momentum

Oct 13, 2026

Proactive Equities Team

Alvo Minerals (ASX: ALV) shares jumped over 17% on strong volume after Bluebush heavy rare earth drilling results and a $1 million placement, with an investor webinar on Palma and Bluebush due on 14 October.

Codeifai (ASX: CDE): ConnectQR Expansion Brings QR Tools Into AI Platforms

Oct 13, 2026

Proactive Equities Team

Codeifai (ASX: CDE) has expanded ConnectQR across ChatGPT, Claude and Canva, targeting broader user adoption through AI and design platforms while pursuing subscription revenue and developing quantum security and anti-counterfeiting technologies.

Vection Technologies (ASX: VR1): Retelit Deal and FY26 Results Mark Commercial Progress

Oct 13, 2026

Proactive Equities Team

Vection Technologies (ASX: VR1) has secured a A$19.5 million multi-year agreement with Retelit, alongside reporting 14% revenue growth, higher adjusted EBITDA and its first positive operating cash flow as it expands across international markets.

CurveBeam AI (ASX: CVB): HiRise Wins China Approval, Opening Path to Commercial Sales

Oct 13, 2026

Proactive Equities Team

CurveBeam AI (ASX: CVB) has secured Chinese regulatory approval for its HiRise weight-bearing CT scanner, opening a pathway to commercial sales in China, alongside plans for local manufacturing and further progress in AI-based medical imaging.

1...8 9 10...81

Page 9 of 81

1...8 9 10...81

Page 9 of 81